Heraudet, L, Delon, T, Veillon, R, Vergnenègre, C, Lepetit, H, Daste, A et al.. Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non-small cell lung cancer: A retrospective study. Thorac Cancer. 2022;13 (9):1391-1400. doi: 10.1111/1759-7714.14403. PubMed PMID:35434866 PubMed Central PMC9058314.
Blaye, C, Boyer, T, Peyraud, F, Domblides, C, Larmonier, N. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers. Front Immunol. 2022;13 :838040. doi: 10.3389/fimmu.2022.838040. PubMed PMID:35309358 PubMed Central PMC8927658.
Gefard-Gontier, E, Markich, R, Zysman, M, Veillon, R, Daste, A, Domblides, C et al.. Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors. Cancer Immunol Immunother. 2022; :. doi: 10.1007/s00262-022-03180-x. PubMed PMID:35305123 .
Boyer, T, Blaye, C, Larmonier, N, Domblides, C. Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives. Cells. 2022;11 (3):. doi: 10.3390/cells11030554. PubMed PMID:35159363 PubMed Central PMC8834417.
Ramel, E, Lillo, S, Daher, B, Fioleau, M, Daubon, T, Saleh, M et al.. The Metabolic Control of Myeloid Cells in the Tumor Microenvironment. Cells. 2021;10 (11):. doi: 10.3390/cells10112960. PubMed PMID:34831183 PubMed Central PMC8616208.
Haik, L, Gonthier, A, Quivy, A, Gross-Goupil, M, Veillon, R, Frison, E et al.. The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours. Acta Oncol. 2021;60 (12):1597-1603. doi: 10.1080/0284186X.2021.1978540. PubMed PMID:34549686 .
Tudela, H, Claus, SP, Saleh, M. Next Generation Microbiome Research: Identification of Keystone Species in the Metabolic Regulation of Host-Gut Microbiota Interplay. Front Cell Dev Biol. 2021;9 :719072. doi: 10.3389/fcell.2021.719072. PubMed PMID:34540837 PubMed Central PMC8440917.
Lopez, L, Griffier, R, Barnetche, T, Lhomme, E, Kostine, M, Truchetet, ME et al.. The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis. Rheumatology (Oxford). 2022;61 (2):531-541. doi: 10.1093/rheumatology/keab630. PubMed PMID:34382085 .